These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 11831078)

  • 1. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis B virus: a better knowledge of its structure and variations in the expression of the viral disease].
    Bréchot C
    Gastroenterol Clin Biol; 1984; 8(8-9):641-5. PubMed ID: 6386590
    [No Abstract]   [Full Text] [Related]  

  • 3. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of hepatitis B virus DNA cloning in the diagnosis of infections related to hepatitis B virus].
    Bréchot C
    Ann Biol Clin (Paris); 1985; 43(4):351-4. PubMed ID: 3004263
    [No Abstract]   [Full Text] [Related]  

  • 6. A boost to hepatitis B vaccine: no need for boosters.
    Aggarwal R
    Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B monoclonal antibody testing.
    Ben-Porath E; Fujita YK; Wands JR
    Prog Liver Dis; 1986; 8():347-66. PubMed ID: 2424047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Infection by hepatitis B virus and its prevention].
    Kashiwagi S
    Rinsho Byori; 1987 Jan; 35(1):9-16. PubMed ID: 3560486
    [No Abstract]   [Full Text] [Related]  

  • 9. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract]   [Full Text] [Related]  

  • 10. [Viral hepatitis B vaccine].
    Leone G; Melino G
    Clin Ter; 1983 Mar; 104(6):483-93. PubMed ID: 6851450
    [No Abstract]   [Full Text] [Related]  

  • 11. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D; Chevaliez S; Pawlotsky JM
    Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.
    Cooper B
    Compr Ther; 1989 Jul; 15(7):9-15. PubMed ID: 2527714
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis B virus infection: current developments].
    van Ditzhuysen JM; van Loon AM; Yap SH
    Ned Tijdschr Geneeskd; 1983 Nov; 127(48):2193-8. PubMed ID: 6318129
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of virological/serological parameters for hepatitis B].
    Holter E
    Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1965-6. PubMed ID: 1509460
    [No Abstract]   [Full Text] [Related]  

  • 17. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoprophylaxis of hepatitis B. 4. Identification of risk groups, recommendations for inoculation, new developments].
    Zoulek G; Jilg W; Deinhardt F
    Dtsch Med Wochenschr; 1983 Aug; 108(34):1263-8. PubMed ID: 6224668
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infectivity of hepatitis B].
    Gerken G
    Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.